Athanor Capital, LP Athenex, Inc. Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $98,352 - $355,563	-24,106 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $4,711 - $5,968	-426 Reduced 1.74%	24,106 $267,000
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $67,633 - $95,913	-6,592 Reduced 21.18%	24,532 $297,000
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $221,291 - $428,266	31,124 New	31,124 $428,000
Q1 2020 May 14, 2020	SELL	$5.71 - $15.85 $196,424 - $545,240	-34,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $95,040 - $175,725	9,900 Added 40.41%	34,400 $525,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $297,920 - $514,500	24,500 New	24,500 $298,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.